Olopatadine Hydrochloride Solution/ Drops
Product Images NDC 46708-710

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olopatadine Hydrochloride (NDC 46708-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olopatadine-bottle-alembic (Olopatadine Bottle Alembic)

Olopatadine-bottle-alembic (Olopatadine Bottle Alembic)
This is a description of olopatadine hydrochloride ophthalmic solution, which is an antihistamine used for eye allergy itch relief. It comes in a 25mL sterile bottle for once-daily use. The product is intended for use in the eye and should be stored between 2°C and 25°C. The manufacturer is Alembic Pharmaceuticals Limited. The description also includes a warning about tamper evidence, instructing not to use if the ring at the bottom of the cap is broken or missing at the time of purchase. The lot number is indicated as 200XXXXX.*
FDA Label Image

Olopatadine-carton-alembic (Olopatadine Carton Alembic)

Olopatadine-carton-alembic (Olopatadine Carton Alembic)
This is a drug information leaflet for Olopatadine Hydrochloride, an ophthalmic solution used as an Antihistamine for relief from itchy eyes due to pollen or ragweed allergies. It provides directions for use, warnings, ingredients, dosage information for different age groups, inactive ingredients, and contact details for Alembic Pharmaceuticals. The leaflet emphasizes the temporary relief of eye allergy symptoms and the importance of proper usage and storage of the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.